Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Imaging In Clinical Trials Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Imaging In Clinical Trials Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Imaging In Clinical Trials Overall Market Size
2.1 Global Imaging In Clinical Trials Market Size: 2021 VS 2028
2.2 Global Imaging In Clinical Trials Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Imaging In Clinical Trials Players in Global Market
3.2 Top Global Imaging In Clinical Trials Companies Ranked by Revenue
3.3 Global Imaging In Clinical Trials Revenue by Companies
3.4 Top 3 and Top 5 Imaging In Clinical Trials Companies in Global Market, by Revenue in 2021
3.5 Global Companies Imaging In Clinical Trials Product Type
3.6 Tier 1, Tier 2 and Tier 3 Imaging In Clinical Trials Players in Global Market
3.6.1 List of Global Tier 1 Imaging In Clinical Trials Companies
3.6.2 List of Global Tier 2 and Tier 3 Imaging In Clinical Trials Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Imaging In Clinical Trials Market Size Markets, 2021 & 2028
4.1.2 Services
4.1.3 Software
4.2 By Type - Global Imaging In Clinical Trials Revenue & Forecasts
4.2.1 By Type - Global Imaging In Clinical Trials Revenue, 2017-2022
4.2.2 By Type - Global Imaging In Clinical Trials Revenue, 2023-2028
4.2.3 By Type - Global Imaging In Clinical Trials Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Imaging In Clinical Trials Market Size, 2021 & 2028
5.1.2 Biotechnology Companies
5.1.3 Pharmaceutical Companies
5.1.4 Medical Device Manufacturers
5.1.5 Government and Academic Institutions
5.1.6 Others
5.2 By Application - Global Imaging In Clinical Trials Revenue & Forecasts
5.2.1 By Application - Global Imaging In Clinical Trials Revenue, 2017-2022
5.2.2 By Application - Global Imaging In Clinical Trials Revenue, 2023-2028
5.2.3 By Application - Global Imaging In Clinical Trials Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Imaging In Clinical Trials Market Size, 2021 & 2028
6.2 By Region - Global Imaging In Clinical Trials Revenue & Forecasts
6.2.1 By Region - Global Imaging In Clinical Trials Revenue, 2017-2022
6.2.2 By Region - Global Imaging In Clinical Trials Revenue, 2023-2028
6.2.3 By Region - Global Imaging In Clinical Trials Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Imaging In Clinical Trials Revenue, 2017-2028
6.3.2 US Imaging In Clinical Trials Market Size, 2017-2028
6.3.3 Canada Imaging In Clinical Trials Market Size, 2017-2028
6.3.4 Mexico Imaging In Clinical Trials Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Imaging In Clinical Trials Revenue, 2017-2028
6.4.2 Germany Imaging In Clinical Trials Market Size, 2017-2028
6.4.3 France Imaging In Clinical Trials Market Size, 2017-2028
6.4.4 U.K. Imaging In Clinical Trials Market Size, 2017-2028
6.4.5 Italy Imaging In Clinical Trials Market Size, 2017-2028
6.4.6 Russia Imaging In Clinical Trials Market Size, 2017-2028
6.4.7 Nordic Countries Imaging In Clinical Trials Market Size, 2017-2028
6.4.8 Benelux Imaging In Clinical Trials Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Imaging In Clinical Trials Revenue, 2017-2028
6.5.2 China Imaging In Clinical Trials Market Size, 2017-2028
6.5.3 Japan Imaging In Clinical Trials Market Size, 2017-2028
6.5.4 South Korea Imaging In Clinical Trials Market Size, 2017-2028
6.5.5 Southeast Asia Imaging In Clinical Trials Market Size, 2017-2028
6.5.6 India Imaging In Clinical Trials Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Imaging In Clinical Trials Revenue, 2017-2028
6.6.2 Brazil Imaging In Clinical Trials Market Size, 2017-2028
6.6.3 Argentina Imaging In Clinical Trials Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Imaging In Clinical Trials Revenue, 2017-2028
6.7.2 Turkey Imaging In Clinical Trials Market Size, 2017-2028
6.7.3 Israel Imaging In Clinical Trials Market Size, 2017-2028
6.7.4 Saudi Arabia Imaging In Clinical Trials Market Size, 2017-2028
6.7.5 UAE Imaging In Clinical Trials Market Size, 2017-2028
7 Players Profiles
7.1 Bioclinica
7.1.1 Bioclinica Corporate Summary
7.1.2 Bioclinica Business Overview
7.1.3 Bioclinica Imaging In Clinical Trials Major Product Offerings
7.1.4 Bioclinica Imaging In Clinical Trials Revenue in Global Market (2017-2022)
7.1.5 Bioclinica Key News
7.2 PAREXEL International Corporation
7.2.1 PAREXEL International Corporation Corporate Summary
7.2.2 PAREXEL International Corporation Business Overview
7.2.3 PAREXEL International Corporation Imaging In Clinical Trials Major Product Offerings
7.2.4 PAREXEL International Corporation Imaging In Clinical Trials Revenue in Global Market (2017-2022)
7.2.5 PAREXEL International Corporation Key News
7.3 Intrinsic Imaging
7.3.1 Intrinsic Imaging Corporate Summary
7.3.2 Intrinsic Imaging Business Overview
7.3.3 Intrinsic Imaging Imaging In Clinical Trials Major Product Offerings
7.3.4 Intrinsic Imaging Imaging In Clinical Trials Revenue in Global Market (2017-2022)
7.3.5 Intrinsic Imaging Key News
7.4 WorldCare Clinical, LLC
7.4.1 WorldCare Clinical, LLC Corporate Summary
7.4.2 WorldCare Clinical, LLC Business Overview
7.4.3 WorldCare Clinical, LLC Imaging In Clinical Trials Major Product Offerings
7.4.4 WorldCare Clinical, LLC Imaging In Clinical Trials Revenue in Global Market (2017-2022)
7.4.5 WorldCare Clinical, LLC Key News
7.5 ICON plc
7.5.1 ICON plc Corporate Summary
7.5.2 ICON plc Business Overview
7.5.3 ICON plc Imaging In Clinical Trials Major Product Offerings
7.5.4 ICON plc Imaging In Clinical Trials Revenue in Global Market (2017-2022)
7.5.5 ICON plc Key News
7.6 KEOSYS Medical Imaging
7.6.1 KEOSYS Medical Imaging Corporate Summary
7.6.2 KEOSYS Medical Imaging Business Overview
7.6.3 KEOSYS Medical Imaging Imaging In Clinical Trials Major Product Offerings
7.6.4 KEOSYS Medical Imaging Imaging In Clinical Trials Revenue in Global Market (2017-2022)
7.6.5 KEOSYS Medical Imaging Key News
7.7 MEDIAN Technologies
7.7.1 MEDIAN Technologies Corporate Summary
7.7.2 MEDIAN Technologies Business Overview
7.7.3 MEDIAN Technologies Imaging In Clinical Trials Major Product Offerings
7.7.4 MEDIAN Technologies Imaging In Clinical Trials Revenue in Global Market (2017-2022)
7.7.5 MEDIAN Technologies Key News
7.8 Navitas Life Sciences(TAKE Solutions)
7.8.1 Navitas Life Sciences(TAKE Solutions) Corporate Summary
7.8.2 Navitas Life Sciences(TAKE Solutions) Business Overview
7.8.3 Navitas Life Sciences(TAKE Solutions) Imaging In Clinical Trials Major Product Offerings
7.8.4 Navitas Life Sciences(TAKE Solutions) Imaging In Clinical Trials Revenue in Global Market (2017-2022)
7.8.5 Navitas Life Sciences(TAKE Solutions) Key News
7.9 Mint Medical GmbH
7.9.1 Mint Medical GmbH Corporate Summary
7.9.2 Mint Medical GmbH Business Overview
7.9.3 Mint Medical GmbH Imaging In Clinical Trials Major Product Offerings
7.9.4 Mint Medical GmbH Imaging In Clinical Trials Revenue in Global Market (2017-2022)
7.9.5 Mint Medical GmbH Key News
7.10 Radiant Sage Ventures
7.10.1 Radiant Sage Ventures Corporate Summary
7.10.2 Radiant Sage Ventures Business Overview
7.10.3 Radiant Sage Ventures Imaging In Clinical Trials Major Product Offerings
7.10.4 Radiant Sage Ventures Imaging In Clinical Trials Revenue in Global Market (2017-2022)
7.10.5 Radiant Sage Ventures Key News
7.11 Resonance Health
7.11.1 Resonance Health Corporate Summary
7.11.2 Resonance Health Business Overview
7.11.3 Resonance Health Imaging In Clinical Trials Major Product Offerings
7.11.4 Resonance Health Imaging In Clinical Trials Revenue in Global Market (2017-2022)
7.11.5 Resonance Health Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer